New Zones Report
Proving it Works: Cosmeceutical Claims Testing Report
This comprehensive report delivers the strategic framework and technical specifications you need to build defensible claims, design compliance-first development processes, and succeed at the beauty-pharma intersection where regulatory scrutiny is reshaping competitive advantage.

Who should read the report
R&D and formulation, regulatory, business decision-makers at beauty-pharma intersection, brand owners and product managers, pharma and consumer-health sectors.
Key insights you'll gain
- Claims-First Development Framework
Discover how determining claim wording and evidence requirements at formulation stage transforms regulatory compliance into competitive advantage, enabling defensible "clinically proven" positioning while controlling testing costs and development timelines across global markets.
- Multi-Regime Evidence Architecture
Learn how to build a single, governed evidence file satisfying efficacy, environmental, ethical, and manufacturing standards simultaneously—with jurisdiction-specific versioning for EU, UK, US MoCRA, China NMPA, and Korea MFDS requirements that eliminates costly duplicate testing and late-stage compliance failures.
Introduction
Setting the stage for transformation in Americas pharmaceutical manufacturing
Innovation, Resilience, and Strategy – the CPHI Americas Roundtable
Exclusive perspectives from industry thought leaders on building resilient supply chains and embracing collaborative ecosystems
Beyond the Stage: Conference Insights
Key takeaways from five dedicated content tracks covering R&D, sustainability, the LATAM pharma landscape, Women's Networking Event, and more
Start-Up Stories: Zymvol Biomodeling
Breakthrough innovations from emerging companies reshaping the pharmaceutical value chain
Sustainability in a Fragmented Global Economy
Practical strategies for environmental responsibility amid supply chain complexity and regulatory diversity
The Road to Miami 2027
Why Miami's emergence as a pharmaceutical hub matters for your business—from world-class logistics infrastructure to business-friendly environment and growing industry presence
Contributors
Meet the experts and organizations shaping the conversation
References
Supporting data and sources
Download the report
New zone 2027: Cosmeceuticals
Clinical skincare meets pharma for the first time
A founding focus zone at CPHI Frankfurt 2027: an exclusive space where science-led, clinically substantiated skincare connects with the pharmaceutical buyers driving the future of the category.
Frankfurt, Germany, 9-11 November 2027
New zone
Cosmeceuticals
As demand grows for evidence-led skincare, clinically substantiated ingredients, advanced formulations and dermocosmetic products are moving closer to the pharma ecosystem.
The companies behind them will be familiar from our API and CDMO zones, but the new Cosmeceuticals zone at CPHI Frankfurt 2027 will bring this growing audience together for the first time.
A $75–90B market growing 7–10% CAGR through 2030
Rising demand for clinically proven, evidence-led skincare is accelerating category growth
Dermocosmetic decision-makers are driving premium pharmacy and clinic expansion
Cosmeceuticals zone
Who you could meet
The pharma side of beauty; buyers who evaluate cosmeceuticals as a pharma-grade opportunity:
Brand owners
building dermocosmetic portfolios.
R&D & formulation teams
sourcing clinically substantiated actives and delivery systems.
Business development & sourcing leaders
finding contract-manufacturing and innovation partners.
Regulatory & compliance professionals
substantiating claims.
Pharma, consumer-health & wellness decision-makers
exploring cosmeceutical opportunities.
CPHI in numbers
Europe's largest pharmaceutical event
Exhibit
Secure your founding exhibitor position in the Cosmeceutical zone at CPHI Frankfurt 2027, helping to define the future of evidence-led cosmetics within pharma.
Attend
Experience CPHI Frankfurt 2027 first-hand before joining the founding cohort of the Cosmeceutical zone.
